Bank of America
TCRT icon

Bank of America’s Alaunos Therapeutics TCRT Stock Holding History

Bank of America’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-382
Closed -$315K – 7343
2016
Q2 		$315K Sell
382
-167
-30% -$182K ﹤0.01% 4969
2016
Q1 		$611K Buy
+549
New +$562K ﹤0.01% 4472
2015
Q1 		– Sell
-222
Closed -$169K – 7546
2014
Q4 		$169K Sell
222
-44
-17% -$23.4K ﹤0.01% 5488
2014
Q3 		$105K Sell
266
-39
-13% -$18.8K ﹤0.01% 5972
2014
Q2 		$185K Buy
305
+198
+185% +$110K ﹤0.01% 5636
2014
Q1 		$74K Buy
107
+14
+15% +$9.38K ﹤0.01% 6199
2013
Q4 		$60K Sell
93
-10
-10% -$5.96K ﹤0.01% 6453
2013
Q3 		$61K Buy
103
+86
+506% +$38.8K ﹤0.01% 6299
2013
Q2 		$5K Buy
+17
New +$4.72K ﹤0.01% 7364

Other funds holding TCRT

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Bank of America's TCRT Position: Q1 2026 in Review

Bank of America sold out of Alaunos Therapeutics (TCRT) in Q1 2026, closing a stake of 89 shares — an estimated $287 sold.

Bank of America first reported a position in TCRT in Q2 2013 and held it in 51 quarters. The position peaked at $6.02M in Q2 2015. 29 funds tracked by Wall St. Rank hold TCRT as of Q1 2026.

  • Bank of America reported no remaining Alaunos Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 89 Alaunos Therapeutics shares in Q1 2026, an estimated $287.
  • Bank of America first reported a position in Alaunos Therapeutics in Q2 2013 and held it in 51 quarters.
  • Bank of America's Alaunos Therapeutics position peaked at $6.02M in Q2 2015.
  • 29 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.